Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG3XJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,396
Award facts
- Contract value 100% obligated
- $40,396.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $40,396.24 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure. This delivery order was issued on January 28, 2026, with an ultimate completion date of January 29, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor providing critical medical products to federal government agencies.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the delivery of a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and veterans' facilities worldwide. The Ozempic delivery supports federal medical supply chain requirements, consistent with the contractor's extensive portfolio of pharmaceutical products spanning diabetes management, specialty medications, and other therapeutic domains across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DR26FG3XJ?
SPE2DR26FG3XJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FG3XJ worth?
The government has obligated $40,396 on SPE2DR26FG3XJ.
Is contract SPE2DR26FG3XJ an order under another contract?
Yes. SPE2DR26FG3XJ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3XJ competed?
The extent of competition for SPE2DR26FG3XJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award